A phase 2 trial of complete resection for stage IV melanoma: results of Southwest Oncology Group Clinical Trial S9430
about
Long-term survival as a treatment benchmark in melanoma: latest results and clinical implicationsThe GIST of targeted therapy for malignant melanomaOptimal management of metastatic melanoma: current strategies and future directionsPDGFRα up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation.Therapy for metastatic melanoma: the past, present, and future.Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)Surgery for distant melanoma metastasis.The expression of p-STAT3 in stage IV melanoma: risk of CNS metastasis and survival.Safety, correlative markers, and clinical results of adjuvant nivolumab in combination with vaccine in resected high-risk metastatic melanoma.Dermal melanoma: A report on prognosis, outcomes, and the utility of sentinel lymph node biopsy.The prognostic role of the preoperative absolute lymphocyte count and absolute monocyte count in patients with resected advanced melanoma.Current and planned multicenter trials for patients with primary or metastatic melanoma.Metastatic melanoma to the upper aerodigestive tract: a systematic review of the literature.Post-operative survival following metastasectomy for patients receiving BRAF inhibitor therapy is associated with duration of pre-operative treatment and elective indication.Clinical correlates and prognostic value of different metastatic sites in patients with malignant melanoma of the skin: a SEER database analysis.Principles of Kinase Inhibitor Therapy for Solid Tumors.The Role of Surgery for Melanoma in an Era of Effective Systemic Therapy.Treatment patterns, outcomes, and resource utilization of patients with metastatic melanoma in the U.K.: the MELODY study.Targeted therapies in melanoma.Melanoma: the role of surgery in the era of new therapies.Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases.Stage IV melanoma: completely resectable patients are scarce.Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma.Prolonged survival after surgical management of metastases in malignant melanoma: three case reports.Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial)Surgical resection of metastatic melanoma in the era of immunotherapy and targeted therapy
P2860
Q26775546-2FEC45E3-F6D1-4080-A10C-E88EC8DDFCCEQ26827092-E8297CB8-5D36-4D44-B82C-47F710096AE2Q26997338-CBB0655C-B717-4AEC-A709-C278C3A7C461Q33688428-F244BC1B-294C-4405-8000-3010FB6B19C8Q34183225-C2A23942-EFBB-40E6-A8F7-A65439E972F4Q34286994-E532C983-791C-4810-A5CC-124F2D2FBF5DQ34636992-ABBC0BF9-B6A7-4A71-A5F9-DA52D7A41610Q35987091-B3E37917-81BC-4787-B091-B12067DC3232Q36206582-C2909CE8-F185-47A4-9D37-B68A90E6B4EAQ36997179-9C94F37D-A671-459B-BAF0-1E318D06D541Q37395913-D500CFD1-7E64-4BC7-923A-99BD18AFD036Q37920844-2368DF8F-A0C5-4336-ACFB-3E68E57254F9Q38151617-D4B4A26F-9D8C-4283-BE38-3E86051A4760Q38529540-F09E0F03-19BB-41FC-B79E-3B6C2F1C2750Q38660616-425ADD18-7814-4D63-8F1A-09CAE31B11EFQ38802154-68884B04-463E-484B-954F-A8241F4305C9Q39157489-9FE1AB1F-327D-40D1-ACD3-AE80A3721A33Q39384594-8D8DA077-DBD9-4069-91B1-CC59D76A7B75Q41268316-5ABB2E28-D960-4375-9DE8-7705B437A0B4Q42744580-6CE7A73C-EE29-4A7D-B660-C96BEBC2D610Q46847441-6D67C8A2-A67F-440A-9741-DEA1F3A93DD5Q50873280-B1B73824-AAE5-4B87-B525-A559952B0186Q55022893-344231CB-6A22-43F9-B45F-5E5715CF88C7Q55112494-29B21FA7-C33A-4093-9B8E-3E5DCBF4E805Q56523838-462A6D18-9A42-496E-AF20-0C6EEA70F567Q56894275-9DD1C44D-AA62-4CAE-ACE8-DB12C4CAA763
P2860
A phase 2 trial of complete resection for stage IV melanoma: results of Southwest Oncology Group Clinical Trial S9430
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A phase 2 trial of complete re ...... ogy Group Clinical Trial S9430
@ast
A phase 2 trial of complete re ...... ogy Group Clinical Trial S9430
@en
type
label
A phase 2 trial of complete re ...... ogy Group Clinical Trial S9430
@ast
A phase 2 trial of complete re ...... ogy Group Clinical Trial S9430
@en
prefLabel
A phase 2 trial of complete re ...... ogy Group Clinical Trial S9430
@ast
A phase 2 trial of complete re ...... ogy Group Clinical Trial S9430
@en
P2093
P2860
P356
P1433
P1476
A phase 2 trial of complete re ...... ogy Group Clinical Trial S9430
@en
P2093
Bruce G Redman
James A Warneke
James Moon
Jeffrey A Sosman
John T Vetto
Joseph M Unger
Lawrence E Flaherty
Ralph J Tuthill
Vernon K Sondak
P2860
P304
P356
10.1002/CNCR.26111
P407
P577
2011-03-31T00:00:00Z